Trials
2 active
10 in total · 1 in the EU
What this is
- How it works
- Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor FDA class
- How it’s given
- “A single oral dose of 3000 mg gepotidacin will be administered”In the company’s words, NCT07645235 on ClinicalTrials.gov
- Tested for
- Urinary Tract Infections (2 trials)
- Main trialPhase 1
- “This study aims to evaluate the pharmacokinetic of gepotidacin in fed healthy lactating women.”In the company’s words, NCT07645235 on ClinicalTrials.gov
- Other names
- GSK2140944
Other drugs for Urinary Tract Infections
- U101TCM Biotech International Corp. · Phase 3
- Candidate UTI vaccineGSK · Phase 1/2
- LBP-EC01Locus Biosciences · Phase 2
- JKN2501Joincare Pharmaceutical Group Industry Co., Ltd · Phase 1
Coming up2
- 17 May 2027Phase 1 trial completes · ClinicalTrials.gov
- 23 Aug 2027Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials10
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | 17 May 2027 | A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women | |
| Phase 1Not yet recruiting | 23 Aug 2027 | A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics | |
| Phase 3Completed | 30 Nov 2022 | A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) | |
| Phase 3Completed | 1 Dec 2022 | Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI) | |
| Phase 3Completed | 10 Oct 2023 | A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea | |
| Phase 3Completed | 2 Feb 2024 | A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis) | |
| Phase 3Completed | 10 Mar 2025 | A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis) | |
| Phase 1Completed | 26 Dec 2018 | Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function | |
| Phase 1Completed | 21 Dec 2020 | Drug-drug Interaction Study of Gepotidacin | |
| Phase 1Completed | 22 Apr 2022 | A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026